Welcome to Eloquest Healthcare!

About Our Company

Eloquest Healthcare Inc. is a wholly owned subsidiary of Ferndale Pharma Group, Inc. that is focused specifically on serving hospitals, their clinicians, and patients. We collaborate with our customers to deliver safer, more compassionate care.

Eloquest Healthcare’s products support strategies that prevent hospital acquired infections and provide better outcomes, higher quality and lower healthcare costs.

Our Products

Why Partner With Us?

null
null

Better Clinical Outcomes

Reduced risk of central line-associated bloodstream infections (CLABSI), post-op wound contamination, and skin injuries.
null
null

Higher Quality Support

Educational resources, knowledgeable field representatives, home office support.
null
null

Lower Cost of Care

Reduced material cost from waste and lower payment penalties from improvement in care quality.

3 Main Reasons to Choose Eloquest

Better Clinical Outcomes

We strive for better clinical outcomes. Eloquest Healthcare works towards reduced risk of central line-associated bloodstream infections (CLABSI), post-op wound contamination, and skin injuries.

Higher Quality Support

You’re not alone. Eloquest Healthcare takes pride in providing higher quality support to you and your facility. Educational resources, knowledgeable field representatives, home office support are just a few of the things we provide for you.

Lower Cost of Care

Eloquest Healthcare aims to lower your facility’s cost of care through reduced material cost from waste and lower payment penalties from improvement in care quality.

RECENT NEWS & EVENTS

february, 2019

No Events

“Stressing the Dressing: Reducing Vascular Access Device Complications”

The US Centers for Disease Control and Prevention (CDC) and The Infusion Nurses Society (INS) agree that vascular access device (VAD) dressing integrity is a critical factor for the prevention of hospital-acquired infection.1,2 Russell Nassof, JD, founder of RiskNomics, discusses the importance of common sense in evidenced-based medicine, the issue of dressing disruption, the prominence…

Read more

‘The Cutting Edge’: Using New Technology to Improve Surgical Outcomes

Toni Polk, BSN, RN, CIC, Infection Preventionist at Christus Trinity Mother Frances Hospital in Tyler, Texas, reviews rates of surgical site infections, the importance of preventing surgical site infections, and her experience trialing a novel product in a 45-minute educational webinar available here. In this blog, we’ll provide the highlights of her presentation. Infections Are…

Read more

Evidence-Based Decision Making for the Prevention of Catheter-Related Bloodstream Infections and Medical Adhesive-Related Skin Injuries

While catheters provide numerous benefits to their users, there can be a health burden associated with their use, as they may promote catheter-related bloodstream infection (CRBSI*) and medical adhesive-related skin injuries (MARSIs). A publication reviewing the qualitative and quantitative evidence supporting the use of Detachol® Liquid Adhesive for the reduction of CRBSI and MARSI can…

Read more